Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | KLK3 |
| Upstream (Parents) |
|---|
| (<<) CD4 → KLK3 |
| (<<) CDH22 → KLK3 |
| (<<) CTRB2 → KLK3 |
| (<<) DAZAP2 → KLK3 |
| (<<) E2F4 → KLK3 |
| (<<) HDAC11 → KLK3 |
| (<<) IL23A → KLK3 |
| (<<) MAP3K10 → KLK3 |
| (<<) PLD3 → KLK3 |
| (<<) PTMA → KLK3 |
| (<<) SLC34A3 → KLK3 |
| (<<) UTS2R → KLK3 |
| Downstream (Children) |
|---|
| KLK3 → ACTC1 (>>) |
| KLK3 → ANXA2 (>>) |
| KLK3 → ATP10B (>>) |
| KLK3 → DEPDC7 (>>) |
| KLK3 → EXOC3L2 (>>) |
| KLK3 → FER1L4 (>>) |
| KLK3 → FLJ35390 (>>) |
| KLK3 → GSK3A (>>) |
| KLK3 → HMOX1 (>>) |
| KLK3 → IL1F7 (>>) |
| KLK3 → KLK12 (>>) |
| KLK3 → MMP14 (>>) |
| KLK3 → NDOR1 (>>) |
| KLK3 → PRSS36 (>>) |
| KLK3 → PTAFR (>>) |
| KLK3 → RAB5C (>>) |
| KLK3 → RHOT2 (>>) |
| KLK3 → SEMA5B (>>) |
| KLK3 → SPPL2B (>>) |
| KLK3 → SYNJ2 (>>) |
| KLK3 → T (>>) |
| KLK3 → TPSG1 (>>) |
| KLK3 → UBE2D2 (>>) |
| KLK3 → UBE2I (>>) |
| KLK3 → WNT7A (>>) |
